Drug intelligence / Profile preview

VCL-NB01

Development stage
Discontinued
Lead developer
Vical
Modality
Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intramuscular
01

Overview

VCL-NB01 is an experimental DNA plasmid-based veterinary vaccine developed by Vical for the prevention of necrotic bovine pododermatitis, commonly known as foot rot, in cattle. The vaccine consists of a DNA plasmid encoding the leukotoxin (LKT) of *Fusobacterium necrophorum*, which is the primary causative agent of the disease. Upon intramuscular injection, the plasmid is taken up by the animal's cells, leading to the expression of the LKT protein and the subsequent induction of a protective immune response. This DNA-based approach was intended to offer improved efficacy and safety compared to traditional killed-bacteria vaccines (bacterins) by specifically targeting a key virulence factor of the pathogen.

Other names
Bovine foot rot DNA vaccine
02

Targets

Lkt (Fusobacterium necrophorum leukotoxin)

Beyond the preview

Go deeper on VCL-NB01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VCL-NB01.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call